Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Journal
Type
Date
Availability
1-2 of 2
Keywords: National policy
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
International Journal of Pharmaceutical and Healthcare Marketing (2013) 7 (2): 199–215.
Published: 21 June 2013
... accountability” (Council on Foreign Relations, 2012) under a “loosely configured complex” (Fidler, 2010). Product testing Immunization Preventative medicine Japan United Kingdom United States of America National cultures Clinical trials Vaccine approval National policy Regulation Immunological...
Journal Articles
International Journal of Pharmaceutical and Healthcare Marketing (2013) 7 (1): 45–57.
Published: 29 March 2013
... to determine whether or not the drug is producing effective results. Both Phases I and II, have short‐term study periods ranging from one to six months. © Emerald Group Publishing Limited 2013 Clinical trial Vaccine designations National policy Public health Preventative medicine...
